UNIQUE BUSINESS IDENTIFIER / CRN
UBI 62586034
CRN 2021391
Live BRN: 62586034 CRN: 2021391 Established 4 Years

yingli pharma hk limited

Yingli Pharma (HK) Limited

Record Updated: 2025-10-09
Inquiries: 155 Views
Jurisdiction: Hong Kong SAR

yingli pharma hk limited (Yingli Pharma (HK) Limited) is a Hong Kong corporation duly incorporated under the Companies Ordinance (Cap. 622). Its official Company Registration Number (CRN) is 2021391, and Business Registration Number (BRN) is 62586034, classified as a Private company limited by shares. Incorporated on 2022-04-24 00:47:05, the entity has maintained continuous statutory operations for 4 years, currently holding an active legal status of Live. The Hong Kong Companies Registry maintains 10 official statutory filing records for this corporation (including historical Annual Returns NAR1, Incorporation Form NNC1, and Articles of Association).

I. yingli pharma hk limited - Corporate Profile & Statutory Registry Records

yingli pharma hk limited Official Hong Kong Corporate Registry Specifications
Official Chinese Name Yingli Pharma (HK) Limited Official English Name yingli pharma hk limited
Business Reg No. (BRN / UBI) 62586034 Company Reg No. (CRN) 2021391
Company Category Private company limited by shares Incorporation Date 2022-04-24 00:47:05
Current Legal Status Live Statutory Filing Cycle 2026-04-24
Registered Office Address
Address maintained in statutory filings (NAR1/NNC1). Available via Registry extract.
Significant Controllers (SCR) Pursuant to Part 12 Division 2A of Cap. 622, SCR records are kept at the registered office. Order our Due Diligence Report to penetrate UBO controllers.

II. yingli pharma hk limited - Companies Registry Statutory Image Records

Document Index Notice:Official statutory image records of target corporation. Order to retrieve authentic filing documents in PDF format.
#Filing DateDocument No.Document NamePagesTariffAction
1 2022-05-20 40019034267
751(1)Statutory Regulatory / Strike-off Reference Document
2022-05-20·40019034267·1p·HK$ 20
1 HK$ 20
2 2022-03-29 22101729531
R1Notice of Change of Registered Office Address
2022-03-29·22101729531·4p·HK$ 20
4 HK$ 20
3 2022-02-08 23202140326
NAR1Annual Return 2022
2022-02-08·23202140326·10p·HK$ 28
10 HK$ 28
4 2021-07-09 23601539400
ND2BNotice of Change of Company Secretary and Director Details
2021-07-09·23601539400·3p·HK$ 20
3 HK$ 20
5 2021-06-21 23401891696
NNC2Statutory Filing Document
2021-06-21·23401891696·1p·HK$ 20
1 HK$ 20
6 2021-06-21 40017940045
REG_REFStatutory Filing Document
2021-06-21·40017940045·1p·HK$ 20
1 HK$ 20
7 2021-01-27 22802231575
NAR1Annual Return 2021
2021-01-27·22802231575·10p·HK$ 28
10 HK$ 28
8 2020-02-14 23201822643
NAR1Annual Return 2020
2020-02-14·23201822643·10p·HK$ 28
10 HK$ 28
9 2019-03-13 22401739221
NNC2Statutory Filing Document
2019-03-13·22401739221·1p·HK$ 20
1 HK$ 20
10 2019-03-13 40014775746
REG_REFStatutory Filing Document
2019-03-13·40014775746·1p·HK$ 20
1 HK$ 20

III. yingli pharma hk limited - Commercial Due Diligence & Regulatory Risk Screening

Statutory Licences (32 Regulators) Standard Entity
No statutory licences registered under 32 Hong Kong regulators (Standard Commercial Corp).
Court Litigation & Dockets No Public Dockets
Screen civil disputes, commercial claims, and criminal dockets across High Court, District Court, and Small Claims Tribunal.
Insolvency & Sanctions Screening Clean Record
Cross-check Official Receiver’s Office records for compulsory winding-up petitions, liquidator appointments, and creditor notices.
Office & Address Verification Pending Registry Extract
Address maintained in statutory filings (NAR1/NNC1).
Hong Kong Corporate Due Diligence & Risk Screening Service

Click below to connect with our compliance specialist. The system will query statutory directorship records, UBO beneficial ownership mapping, court judgments, and regulatory compliance status.

UBO Ownership Mapping Judicial & Winding-Up Check Senior Specialist Review

IV. yingli pharma hk limited - Authoritative Corporate Dossier & Verification FAQ

Q1Legal Status

Is yingli pharma hk limited a legally registered Hong Kong company? What is its operational status?

yingli pharma hk limited is a legitimate Hong Kong corporation duly incorporated under the Companies Ordinance (Cap. 622) of Hong Kong on 2022-04-24 00:47:05 (operating for 4 years). According to the official register of the Hong Kong Companies Registry (CR), the entity holds an active statutory status of [Live / In Operation].

The statutory identifiers for this corporation issued by Hong Kong SAR authorities are: 1. Business Registration Number (BRN / Unique Business Identifier UBI): [62586034] (effective from 27 December 2023, this 8-digit number serves as the official cross-departmental primary identifier and tax ID); 2. Company Registration Number (CRN): [2021391] (historical archive number issued by Companies Registry). In international banking KYC, trade bills of lading, and cross-border contracts, these two numbers uniquely confirm entity legitimacy.

Under Hong Kong law, incorporated companies do not maintain a 'legal representative' position; the Board of Directors exercises supreme statutory management authority. Under the New Inspection Regime of the Companies Ordinance, public inspection protects directors' personal identification by displaying correspondence addresses and masked ID numbers. To retrieve the complete certified directorship history, shareholding structure (Form NAR1), Significant Controllers Register (SCR), and multi-tier UBO beneficial ownership penetration, apply through 86hc.com for an official due diligence dossier.

According to the statutory registers of the Hong Kong Companies Registry, yingli pharma hk limited has never changed its corporate name since incorporation, maintaining its current registered legal name continuously.

Yes. 86hc.com comprehensively indexes the official filing registers of the Hong Kong Companies Registry, maintaining 10 statutory filing records for this corporation. Pursuant to Section 107 of the Companies Ordinance (Cap. 622), private companies must deliver an Annual Return (Form NAR1) within 42 days of each incorporation anniversary. Available verified original dossiers include: latest Annual Return (Form NAR1 - detailing current share capital, registered office, directors, and shareholders), Incorporation Form (Form NNC1/NC1), Articles of Association, and Change of Company Secretary and Director notices (Form ND2A). Rapid document fulfillment within 15-30 minutes and Certified True Copies (CTC) signed by practicing Hong Kong CPAs are supported.

According to multi-dimensional checks across 32 Hong Kong statutory authorities: 1. Regulatory Licences: Cross-referenced across all 32 Hong Kong statutory regulatory registers (including HKMA, SFC, TCSP, Customs MSO/DPMS), this entity holds no special financial licensing, operating as an ordinary commercial company limited by shares; 2. Judicial Litigation & Winding-Up: screening across the Court of Final Appeal, High Court, District Court, and Official Receiver's Office (ORO) shows no active compulsory winding-up petitions on file.

V. yingli pharma hk limited - Similar Trade Names & Industry Directory